Literature DB >> 34103715

CRISPR-Cas9 can cause chromothripsis.

Fyodor D Urnov1,2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34103715     DOI： 10.1038/s41588-021-00881-4

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  2 in total

1.  Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.

Authors:  Mitchell L Leibowitz; Stamatis Papathanasiou; Phillip A Doerfler; Logan J Blaine; Lili Sun; Yu Yao; Cheng-Zhong Zhang; Mitchell J Weiss; David Pellman
Journal:  Nat Genet       Date:  2021-04-12       Impact factor: 38.330

2.  Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.

Authors:  Gregorio Alanis-Lobato; Jasmin Zohren; Afshan McCarthy; Norah M E Fogarty; Nada Kubikova; Emily Hardman; Maria Greco; Dagan Wells; James M A Turner; Kathy K Niakan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-09       Impact factor: 11.205
  2 in total
  1 in total

1.  CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome.

Authors:  Sujan Ravendran; Sabina Sánchez Hernández; Saskia König; Rasmus O Bak
Journal:  Front Genome Ed       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.